Research summary ·
Metabolic Effects of Testosterone Replacement Therapy in Men with Functional Secondary Hypogonadism, Obesity and Type 2 Diabetes or Metabolic Syndrome: A Systematic Review.
Written based on 1 research study on PubMed, searched on 5 Nov 2026.
What was studied
This review looked at testosterone treatment in obese men with low testosterone. The men also had type 2 diabetes or metabolic syndrome. Only double-blind trials against placebo were included. The review rated risk of bias. It also rated how certain the evidence is.
What they found
The clearest signal was a change in body make-up. Lean mass rose and fat mass fell. Insulin resistance improved in some trials, though results varied. Certainty was low for HOMA-IR, fat mass and lean mass. It was very low for HbA1c, fasting glucose and blood fats. It was also very low for long-term safety.
What it means for patients
The authors say the treatment may improve body make-up and HOMA-IR in carefully selected men. They do not regard it as a diabetes or lipid-lowering treatment.
Why it is not certain yet
The evidence is low certainty at most, the authors say. Effects on blood sugar and blood fats remain very uncertain. They call for larger trials. They also want longer follow-up.
Source
Metabolic Effects of Testosterone Replacement Therapy in Men with Functional Secondary Hypogonadism, Obesity and Type 2 Diabetes or Metabolic Syndrome: A Systematic Review.
PubMed · PMID 42506387We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Male hypogonadism publications